… the N-methyl-D-aspartate (NMDA) and non-NMDA receptors may be of clinical use in
epilepsy, Parkinson's disease, cerebral … of cognitive deficit for a therapeutic action of D-cycloserine. …

… AW, Francis PT, Bowen DM (1991) D-cycloserine, a putative cognitive enhancer, facilitates
activation of the N-methyl-D-aspartate receptor-ionophore complex in Alzheimer brain. …

… the N-methyl-D-aspartate (NMDA) receptor, may serve as a probe for human cerebral NMDA
… of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention. …

… cerebral brain flow (CBF). Secondly, rapamycin promotes the degradation of Aβ and Tau by
activating … shed light on that d-cycloserine improved difficult discriminations in the pattern …

… D-Cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-D-aspartate
receptor-ionophore complex in Alzheimer brain. …

… D-Serine is another agonist at the glycine modulatory site, and D-cycloserine, … putative
cognitive enhancer, facilitates activation of the N-methyl-D-aspartate receptor-ionophore complex …

… is part of a receptor-ionophore complex that includes several modulatory … D-Cycloserine:
a ligand for the N-methyl-D-aspartate coupled … D-Cycloserine treatment of Alzheimer disease. …

… diseases, such as Alzheimer's disease (AD). N-Methyl-D-aspartate receptors (NMDARs)
support … D-Cycloserine, a partial agonist at the glycine site of NMDAR, and the DAAO inhibitor …

… -brain barrier and have a higher potency at the glycine recognition site of the NMDA receptor.
… not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates …

… AW, Francis PT, Bowen DM (1991) D-Cycloserine, a putative cognitive enhancer, facilitates
activation of the N-methyl-D-aspartate receptorionophore complex in Alzheimer brain. …